Print Page | Sign In
AOCD Wednesday Webinar - Nail Diseases
Tell a Friend About This EventTell a Friend
 

This is a live virtual webinar focusing on the topic of Nail Diseases presented by Bradley Glick, DO, FAOCD and brought to you by the American Osteopathic College of Dermatology. This webinar is eligible for up to One (1) AOA Category 1A CME or One (1) AMA PRA Category 1™ Credit.

10/21/2020
When: Wednesday, October 21, 2020
7:00 PM
Where: Virtual via Zoom
United States
Presenter: Bradley Glick, DO, FAOCD
Contact: Shelley Wood
660-665-2184


Online registration is closed.
« Go to Upcoming Event List  


 

 

 

 


 


Nail Diseases: A Case Based Format: The Good, The Bad and The Ugly
Presented by: Bradley Glick, DO, FAOCD
Eligible for up to One (1) AOA Category 1A CME or One (1) AMA PRA Category 1™ Credit

Objectives:

  1. Review nail anatomy
  2. Discuss common nail signs
  3. Evaluate cases

Needs:

  1. New advances in dermatologic treatment
  2. New methods of diagnosis or treatment
  3. Availability of new medication(s) or indication(s)
  4. Development of new technology
  5. Advances in medical knowledge
  6. Legislative, regulatory, or organizational changes effecting patient care

References:

  1. Singal A., Arora R. Indian Deramtol Online J. 2015 Mar-Apr: 6(2): 6774. doi: 10.4103/2229-5178.153002
  2. Daniel R et al. Nails Signs of Systemic Disease. https://doi.org/10.1016/B978-141602356-2.50021-9
  3. Jaller JA, Jaller JJ, Jaller AM, Jaller-Char J, Ferreira S, Ferreira R, Scheinberg M. “Recovery of nail dystrophy potential new therapeutic indication of tofacitinib.” Clinical Rheumatology. 2017; 36:971-973.

Core Competencies: 2, 3, 4, 5, 6, 7

Bio:
Bradley Glick
, DO, FAOCD

Dr. Glick is the Program Director of the Dermatology Residency at Larkin Hospital Palm Springs Campus, a LECOM OPTI, Clinical Assistant Professor of Dermatology at the FIU Herbert Wertheim College of Medicine in Miami, FL and Director of Clinical Research at GSI Clinical Research in Margate, FL. Dr. Glick is the current President of the Florida Society for Dermatology and Dermatologic Surgery, Past President of the American Osteopathic College of Dermatology, Board Member of the American Osteopathic Board of Dermatology and serves on the Election Oversite Task Force for the American Academy of Dermatology.

Disclosures: Adviser for: AbbVie, Celgene, Dermavant, Dermira, Lilly, Novartis, Ortho Dermatologics, Pfizer, Sanofi/Genzyme, Sun Pharma, UCB

Investigator for: AbbVie, Celgene, ChemoCentryx, Dermavant, Dermira, Lilly, Sun Pharma

Speaker for: AbbVie, Celgene, Dermavant, Dermira, Janssen, Lilly, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi/Genzyme, Sun Pharma, UCB

Stock Holder of: Top MD 


More Upcoming Wednesday Webinars:

November 4, 2020  Primary Care Dermatology 
James Landero, DO, FAOCD
December 2, 2020  Third World Dermatology
G. Scott Drew, DO, FAOCD 
December 9, 2020  Update on Eczema Atopic Skin
James Q. Del Rosso, DO, FAOCD 

 

Accreditation:
The American Osteopathic College of Dermatology (AOCD) is accredited by the American Osteopathic Association (AOA) to provide Category 1A continuing medical education for physicians.

The American Osteopathic College of Dermatology (AOCD) designates this program for a maximum of 1 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

The American Osteopathic College of Dermatology (AOCD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide AMA PRA Category 1 Credits™ continuing medical education for physicians.

The American Osteopathic College of Dermatology (AOCD) designates this program for a maximum of 1 AMA PRA Category 1 Credit™, and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

 

All webinar presentations are funded in total by the American Osteopathic College of Dermatology. No commercial support is received for production, presentation/webcast, speaker honorarium, or any other purpose. Speakers are instructed to refrain from using product brand names, using company names, and displaying any commercial bias in their presentations.

2902 North Baltimore Street | P.O. Box 7525 | Kirksville, Missouri 63501

660-665-2184 | 1-800-449-2623 | 660-627-2623

General Terms of Use Policy
The AOCD web site and AOCD apps contain copyrighted material and other proprietary information, which may include, but is not limited to: text, software, photos, video, graphics and audio. It is not permitted to modify, publish, transmit, participate in the transfer or sale, create derivative works, or in any way exploit any of the content, in whole or in part.

The AOCD limits permission for downloading education material for personal use only.